Le dépistage du cancer du sein

Le dépistage du cancer du sein
Forum Med Suisse. 2012;12(10):218‒20.
Früherfassung von Brustkrebs
Schweiz Med Forum. 2012;12(10):218‒20.
Références / Literatur
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
U. S. Preventive Services Task Force. Screening for breast cancer: systematic evidence review update for the U. S.
Preventive Services Task Force. AHRQ Publication No. 10–05142–EF-1, Novembre 2009.
Tabar L, Duffy SW, Vitak B, et al. The natural history of breast carcinoma: what have we learned from screening?
Cancer 1999;86:449–462.
Griffin JL, Pearlman MD. Breast cancer screening in women at average risk and high risk. Obstet Gynecol
2010;116(6):1410–21.
Sikles EA. The use of breast imaging to screen women at high risk for cancer. Radiol Clin N Am 2010;48:859–78.
Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355(9198):129–
34.
Bouchardy C, Raymond L, de Wolf C, et al. Prise de position en faveur du dépistage mammographique du cancer du
sein en Suisse. Bull Med Suisses 2001;82:655–61.
International Agency for Research on Cancer. IARC handbooks of cancer prevention, vol. 7, Breast cancer screening.
Lyon: IARCpress, 2002.
Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different
levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ. 2011 Jul
28;343:d4411. doi: 10.1136/bmj.d4411.
Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic
review of incidence trends. BMJ. 2009 Jul 9;339:b2587. doi: 10.1136/bmj.b2587.
Zahl PH, Gøtzsche PC, Mæhlen J. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Lancet Oncol. 2011 Nov;12(12):1118–24.
Semiglazov VF, Manikhas AG, Moiseenko VM, et al. Results of a prospective randomized investigation [Russia
(St.Petersburg)/WHO] to evaluate the significance of self-examination for the early detection of breast cancer. Voprosy Onkologii 2003;49(4):434–41.
Gao DL, Hu YW, Wang WW, et al. Evaluation on the effect of intervention regarding breast self-examination for decreasing breast cancer mortality. Zhonghua Liu Xing Bing Xue Za Zhi 2006;27(11):985–90.
Miller AB, To T, Baines CJ, et al. Canadian National Breast Screening Study-2: 13–year results of a randomized trial
in women aged 50–59 years. J Natl Cancer Inst 2000;92(18):1490–9.
Pisani P, Parkin DM, Ngelangel C, et al. Outcome of screening by clinical examination of the breast in a trial in the
Philippines. Int J Cancer 2006;118(1):149–54.
Köster JP, Gøtzsche PC. Regular self-examination or clinical examination for early detection of breast cancer.
Cochrane Database of Systemic Reviews 2008, Issue 3. DOI: 10.1002/14651858.CD003373
Baxter N, Canadian Task Force on Preventive Health Care. Preventive health care 2001 update: should women be
routinely taught breast self-examination to screen for breast cancer? CMAJ. 2001;164(13):1837–1846.
Smith RA, Cokkinides V, Brooks D, et al. Cancer screening in the United States, 2011: A review of current American
Cancer Society guidelines and issues in cancer screening. CA: Cancer J Clin 2011;61(1):8–30.
Ligue Suisse contre le Cancer. Programme de prévention du cancer du sein: position de la Ligue suisse conre le
cancer 2010.
Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The
screening clinical breast examination: should it be done? How? JAMA 1999;282(13):1270–1280.
Bobo JK, Lee NC. Thames SF. Findings from 752’081 clinical breast examinations reported to a national screening
program from 1995 through 1998. J Natl Cancer Inst 2000;92(12):971–6.
Jatoi I. Screening clinical breast examination. Surg Clin North Am 2003;83(4):789–801.
1
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
Thistlethwaite J, Stewart RA. Clinical breast examination for asymptomatic women exploring the evidence. Aust Fam
Physician 2007;36(3):145–50.
Fenton JJ, Rolnick SJ, Harris EL, et al. Specificity of clinical breast examination in community practice. J Gen Intern
Med. 2007;22(3):332–7.
Chiarelli AM, Majpruz V, Brown P, et al. The contribution of clinical breast examination to the accuracy of breast
screening. J Natl Cancer Inst. 2009;101(18):1236–43.
Wishart GC, Warwick J, Pitsinis V, et al. Measuring performance in clinical breast examination. Br J Surg.
2010;97(8):1246–52.
American College of Obstetricians and Gynecologists. ACOG practice bulletin. Clinical management guidelines for
obstetrician-gynecologists. Number 42, April 2003. Breast cancer screening. Obstet Gynecol 2003;101(4):821–31.
Soo MS, Rosen EL, Baker JA, et al. Negative predictive value of sonography with mammography in patients with
palpable breast lesions. AJR Am J Roentgenol 2001;177:1167–70.
Beyer T, Moonka R. Normal mammography and ultrasonography in the setting of palpable breast cancer. Am J
Surg.2003;185(5):416–9.
Ligue Suisse contre le Cancer. Unis contre le cancer du sein. Les réponses aux questions essentielles. 2010/7.10/15
000 F/2408.
Yankaskas BC, Klabunde CN, Ancelle-Park R, et al International comparison of performance measures for screening
mammography: can it be done? J Med Screen 2004;11:187–93.
Sikles EA. The use of breast imaging to screen women at high risk for cancer. Radiol Clin N Am 2010;48:859–78.
Klabunde C, Bouchard F, Taplin S, et al. Quality assurance for screening mammography: an international comparison. J Epidemiol Community Health 2001;55:204–12.
Kerlikowske K, Grady D, Barclay J, et al. Effect of age, breast density, and family history on the sensitivity of first
screening mammography. JAMA 1996;276(1):33–8.
Rosenberg RD , Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity, and estrogen replacement
therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 1998;209(2):511–8.
Ohuchi N, Ishida T, Kawai M, et al. Randomized Controlled Trial on Effectiveness of Ultrasonography Screening for
Breast Cancer in Women Aged 40–49 (J-START): Research Design. Jpn J Clin Oncol 2011;41(2):275–7.
Berg WA. Tailored supplemental screening for breast cancer: what now and what next? AJR Am J Roentgenol
2009;192(2):390–9.
Pisano ED, Hendrick RE, Yaffe MJ, Baum JK, et al. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology 2008;246(2):376–83.
Wald NJ, Murphy P, Major P, et al. UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ 1995;311(7014):1189–93.
Hackshaw AK, Wald NJ, Michell MJ, et al. An investigation into why two-view mammography is better than one-view
in breast cancer screening.Clin Radiol 2000;55(6):454–8.
Hakama M, Coleman MP, Alexe DM, et al. Cancer screening: evidence and practice in Europe 2008. Eur J Cancer
2008;44(10):1404–13.
Seigneurin A, Exbrayat C, Labarère J, et al. Comparison of interval breast cancer rates for two-versus single-view
screening mammography: a population-based study. Breast. 2009 Oct;18(5):284–8.
Taplin SH, Rutter CM, Finder C, et al. Screening mammography: clinical image quality and the risk of interval breast
cancer. Am J Roentgenol 2002;178(4):797–803.
Birdwell RL, Ikeda DM, O'Shaughnessy KF, Sickles EA. Mammographic characteristics of 115 missed cancers later
detected with screening mammography and the potential utility of computer-aided detection. Radiology 2001
Apr;219(1):192–202.
Warren RML, Duffy SW. Comparison of single reading with double reading of mammograms, and change in effectiveness with experience. Br J Radiology 1995;68:958–62.
Anttinen I, Palmilo M, Soiva M, et al. Double reading of mammography screening films – one radiologist or two? Clin
Radiol 1994;49(8):584–5.
Perry N, Broeders M, de Wolf C, et al. European Guidelines for quality assurance in breast cancer screening and
diagnosis. Fourth edition 2006;188–99.
Elmore JG, Armstrong K, Lehman CD, et al. Screening for breast cancer. JAMA 2005;293(10):1245–56.
Ordonnance fédérale sur les prestations de l’assurance des soins 832.112.31 du 29/09/1995, article 12e.
Ordonnance fédérale sur la garantie de la qualité des programmes de dépistage du cancer du sein réalisé par mammographie 832.102.4 du 23/06/1999.
Bulliard J-L, Ducros C, Dayer E, Arzel B, Levi F. Variation in performance in low-volume mammography screening
programmes: Experience from Switzerland. Cancer Epidemiol 2011; 35: 293–7.)
Perry N, Broeders M, de Wolf C, et al. European Guidelines for quality assurance in breast cancer screening and
diagnosis. Fourth edition 2006;381–94.
Yen MF, Tabar L, Vitak B, et al. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in
breast cancer screening. Eur J Cancer 2003;39(12):1746–54.
Duffy SW, Agbaje O, Tabar L, et al. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis
from two trials of mammographic screening for breast cancer. Breast Cancer Res 2005;7(6):258–65.
Rothenberg LN, Feig SA, Haus AG, et al. A guide to mammography and other breast imaging procedures: NCRP
report n0 149. Bethesda (MD): National Council of radiation protection and measurements; 2004 p 252–66.
Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination,
and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology
2002;225(1):165–75.
Crystal P, Strano SD, Shcharynski S, et al. Using sonography to screen women with mammographically dense
breasts. AJR Am J Roentgenol 2003;181(1):177–82.
Uchida K, Yamashita A, Kawase K, et al. Screening ultrasonography revealed 15% of mammographically occult
breast cancers. Breast Cancer 2008;15(2):165–8.
Berg WA. Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network
(ACRIN) 6666. AJR 2003;180(5):1225–8.
2
59
60
61
62
63
64
65
66
67
68
69
70
71
72
Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography
alone in women at elevated risk of breast cancer. JAMA 2008;299:2151–63.
Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women
with a familial or genetic predisposition. NEJM 2004;351:427–37.
Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK
population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet
2005;365:1769–78
Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and
magnetic resonance imaging. Cancer 2005;103:1898–905.
Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for
surveillance of women at high familial risk for breast cancer. JCO 2005;23:8469–76.
Sardanelli F, Podo F, D’Agnolo G, et al. Multicenter comparative multimodality surveillance of women at geneticfamilial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007;242:698–715.
Lord SJ, Lei W, Craft P, et al. Systematic review of the effectiveness of magnetic resonance imaging (MRI) as an
addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer.
2007;43(13):1905–17.
Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk
prediction. Cancer 1994;73:643–51.
Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1979–86.
Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat
Med 2004;23:1111–30.
Berry DA, Iversen ES Jr, Gudbjartsson DF, et al. BRCAPRO validation, sensitivity of genetic testing of
BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 2002;20:2701–12.
Antoniou AC, Pharoah PP, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast and ovarian
cancer. Br J Cancer 2004;91:1580–90.
Chapuis O. Un dépistage du cancer du sein différent de celui de la population générale: pour quelles femmes et avec
quelles mesures? Rev Med Suisse 2006;2:1296–305.
Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct
to mammography. CA Cancer J Clin 2007;57:75–89.
3